Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Tissue expansion, originally developed for super-resolution imaging, has become a foundation for expansion omics (ExO), a ...

Q32 Bio Inc. ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, today announced ...

Guided by the "Healthy China 2030" strategy, governments, institutions, and enterprises are jointly investing in the health industry, continuously raising residents' health awareness. With the ...

Molecular glues are revolutionizing cancer therapy by targeting undruggable proteins for degradation, enhancing precision ...

Reflects accelerated progression of Phase 2 CALMA trial and pre-clinical small molecule assets. Driven primarily by the $1.1 million non-cash profit from the strategic divestiture of the Vancouver ...

Global South groups oppose ITPGRFA expansion as seed sovereignty and digital biopiracy fears grow; rising farmer protests ...

Ultrasensitive Molecular Amplification Market is projected to reach US$ 31.2 Bn by 2035, driven by rising chronic disease ...

Biotechnology can be used in the packaging of beauty products and has a significant sustainability impact that is good for ...

There is a great demand for more food from the ocean as the global human population rises while their buying power continues to increase in the decades to ...

Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic ...

Mr. Farbstein will present the latest developments in Can-Fite’s advanced stage drug development pipeline including the ...